<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="./datadict_v2.xsl"?><data_table id="pht004311.v1" study_id="phs000794.v1" participant_set="1" date_created="Thu Dec 18 09:52:41 2014"><description>This sample attributes table includes body site where sample was extracted, analyte type, tumor status, histological type, sequence in which sample was collected, first and second line of tumor treatment, and name of sequencing center.</description><variable id="phv00218113.v1"><name>SAMPLE_ID</name><description>De-identified Sample ID</description><type>string</type></variable><variable id="phv00218114.v1"><name>BODY_SITE</name><description>Body site where sample was collected</description><type>string</type></variable><variable id="phv00218115.v1"><name>ANALYTE_TYPE</name><description>Analyte Type</description><type>string</type></variable><variable id="phv00218116.v1"><name>IS_TUMOR</name><description>Tumor status</description><type>encoded values</type><value code="Y+G">Is Tumor+Germline/Constitutive DNA analyzed from the case.</value></variable><variable id="phv00218117.v1"><name>HISTOLOGICAL_TYPE</name><description>Cell or tissue type or subtype of sample</description><type>string</type></variable><variable id="phv00218118.v1"><name>SAMPLE SEQUENCE</name><description>Sample obtained sequentially from Subjects</description><type>string</type><value code="Baseline">Sample collected just before start of Front-line therapy</value><value code="First Relapse">Sample collected from relapse of Front-line therapy before administering secondary therapy</value><value code="Germline">Constitutive DNA obtained from each patient as internal controls</value><value code="PreBaseline">Sample collected 6 months or before starting Front-line therapy</value><value code="Second Relapse">Sample collected from second relapse after secondary therapy</value><value code="Third Relapse">Sample collected after third relapse from therapies</value></variable><variable id="phv00218119.v1"><name>FIRST LINE_TUMOR TREATMENT</name><description>First line therapy given in each case</description><type>encoded values</type><value code="NA">Not Applicable</value><value code="P+C+R">Pentostatin+Cyclophosphamide+Rituximab</value></variable><variable id="phv00218120.v1"><name>SECONDARY TUMOR_TREATMENT</name><description>Seondary therapy provided after relapse</description><type>encoded values</type><value code="CVP-Rituximab">Cyclophosphamide+Vincristine Sulphate+Prednisone+Rituximab</value><value code="CpG">synthetic oligodeoxynucleotides containing unmethylated CG dinucleotides</value><value code="NA">Not Applicable</value><value code="R-CHOP">Rituximab+Cyclophosphamide+Doxorubicin Hydrochloride+Vincristine Sulphate+Prednisone</value></variable><variable id="phv00218121.v1"><name>SEQUENCING_CENTER</name><description>Name of the center which conducted sequencing</description><type>string</type></variable></data_table>
